Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
SYNE1 antisense RNA 2 (SYNE1-AS2)
- Target
- SYNE1-AS2
- Molecular classification
- Other, antisense RNA, long non-coding RNA
01
Overview
SYNE1 antisense RNA 2 (SYNE1-AS2) is a predicted or informatically described antisense long non-coding RNA overlapping or associated with the SYNE1 gene. Antisense RNAs can modulate the expression of their corresponding sense gene through transcriptional interference, epigenetic modification, or RNA-RNA interaction. However, there is currently no direct experimental characterization, disease association, or therapeutic relevance published for SYNE1-AS2 specifically. The SYNE1 gene itself encodes a giant scaffolding protein (Nesprin 1) involved in nuclear envelope organization, and mutations in SYNE1 cause recessive cerebellar ataxias, muscular dystrophy, and other neurologic disorders.
- Other names
- SYNE1-AS2
02
Mechanism of action
Other (no ASO mechanisms described for SYNE1-AS2 directly; general mechanisms for antisense RNAs include modulation of mRNA stability, translation, or chromatin structure)
03
Biological functions
Regulation of SYNE1 gene expression by antisense mechanism (inferred from general knowledge of antisense RNAs)Other
04
Disease associations
Other (no direct disease association described for SYNE1-AS2; the SYNE1 gene is associated with recessive cerebellar ataxias and muscular dystrophies, but this does not directly implicate the antisense RNA)
05
Safety considerations
None specifically known or reported for SYNE1-AS2.
06
Interacting drugs
None reported for SYNE1-AS2. Antisense oligonucleotide (ASO) drugs could in principle target antisense RNAs, but no such drugs are described for SYNE1-AS2 specifically.
07
Biomarkers
None reported for SYNE1-AS2. No evidence it is used as a biomarker in patient selection or monitoring.
Beyond the preview
Go deeper on SYNE1 antisense RNA 2 (SYNE1-AS2).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on SYNE1 antisense RNA 2 (SYNE1-AS2).